| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 |
|---|---|---|---|---|---|---|---|---|---|
Cash Flows From Operating Activities: | |||||||||
Net loss | |||||||||
-4,258 | -3,223 | -4,058 | -4,341 | -5,078 | -4,459 | -4,263 | -3,914 | -5,597 | - |
Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | |||||||||
Depreciation | |||||||||
52 | 35 | 51 | 54 | 53 | 49 | - | - | - | - |
Amortization | |||||||||
349 | 395 | 267 | 210 | 210 | 155 | - | 69 | 10 | - |
Bad debt expense | |||||||||
- | - | - | 0 | - | - | - | - | - | - |
Net loss | |||||||||
- | - | - | - | - | - | - | - | - | -16 |
Depreciation | |||||||||
- | - | - | - | - | - | 37 | 1 | 0 | 0 |
Amortization | |||||||||
- | - | - | - | - | - | 0 | - | - | - |
Accretion of contract liability | |||||||||
- | - | - | - | - | 0 | - | - | - | - |
Bad debt expense | |||||||||
83 | - | 59 | - | -390 | 390 | 0 | - | - | - |
Non-cash lease expense | |||||||||
44 | - | - | - | - | - | - | - | - | - |
Stock-based compensation | |||||||||
306 | 235 | 160 | 392 | 930 | 1,691 | 1,335 | 796 | 2,550 | 0 |
Deferred offering costs | |||||||||
13 | 97 | - | - | - | - | - | - | - | - |
Change in contract liability | |||||||||
- | - | - | -117 | 16 | - | - | - | - | - |
Provision for inventory reserve | |||||||||
-114 | 25 | 2 | 107 | 697 | 328 | 0 | - | - | - |
Impairment charge | |||||||||
- | - | - | 44 | 0 | 5 | - | - | - | - |
Loss on debt conversion | |||||||||
- | - | - | - | - | - | - | -760 | 0 | - |
Impairment charges | |||||||||
- | - | - | - | - | - | - | 0 | 2,662 | 0 |
Interest expense paid in stock | |||||||||
- | - | - | - | - | - | - | - | 0 | - |
Interest expense paid in stock | |||||||||
- | - | - | - | - | - | - | 43 | - | - |
Derivative charges and credits | |||||||||
- | - | - | - | - | - | -28 | -16 | 1,559 | 0 |
Impairment charge | |||||||||
- | - | - | - | - | - | 0 | - | - | - |
Changes in operating assets and liabilities: | |||||||||
(Increase) decrease in accounts receivable | |||||||||
10 | 74 | 55 | -398 | -966 | 727 | 443 | 184 | 17 | 0 |
Decrease (increase) in other asset | |||||||||
-1,124 | 1,124 | - | - | - | - | - | - | - | - |
Decrease (increase) in inventories | |||||||||
-124 | -78 | -81 | 501 | 350 | 1,999 | -76 | -307 | 526 | 0 |
(Increase) decrease in prepaid expenses and other current assets | |||||||||
- | - | - | -437 | -222 | 600 | 61 | -66 | 107 | 0 |
(Increase) decrease in prepaid expenses and other assets | |||||||||
13 | -103 | 78 | - | - | - | - | - | - | - |
Decrease in other asset | |||||||||
-50 | - | - | - | - | - | - | - | - | - |
Increase in accrued interest on promissory note payable | |||||||||
39 | - | - | - | - | - | - | - | - | - |
Decrease in operating lease liabilities | |||||||||
-53 | - | - | - | - | - | - | - | - | - |
Decrease in deferred revenue | |||||||||
- | - | -56 | 0 | - | - | - | - | - | - |
Decrease in accounts payable and accrued expenses | |||||||||
-103 | 203 | -156 | -356 | 471 | 78 | 137 | -309 | 429 | -19 |
Net cash (used in) provided by operating activities | |||||||||
-2,367 | -3,250 | -3,783 | -3,673 | -2,252 | -5,089 | -3,154 | -2,345 | -2,155 | -36 |
Purchases of fixed assets | |||||||||
- | - | 2 | - | - | - | - | - | - | - |
Purchase of capitalized software | |||||||||
- | - | - | 380 | 0 | - | - | - | - | - |
Acquisition of intellectual property | |||||||||
- | - | - | - | - | - | - | 0 | 450 | - |
Purchases of fixed assets | |||||||||
- | - | - | 1 | 27 | 23 | 373 | 6 | 3 | 0 |
Acquisition of intangible assets | |||||||||
- | - | - | - | - | 6 | 2 | 36 | 0 | 0 |
Net cash used in investing activities | |||||||||
- | - | -2 | -381 | -27 | -29 | -375 | -43 | -453 | 0 |
Cash Flows From Financing Activities: | |||||||||
Proceeds from registered direct offering of common stock | |||||||||
211 | 472 | - | - | - | - | - | - | - | - |
Deferred offering costs | |||||||||
- | - | - | 0 | - | - | - | - | - | - |
Advances from related party | |||||||||
250 | - | - | - | 575 | 0 | - | - | - | - |
Payments to related party | |||||||||
250 | - | - | - | - | - | - | - | - | - |
Deferred offering costs from at-the-market transaction | |||||||||
- | 108 | 102 | - | - | - | - | - | - | - |
(Repayments to) advances from related parties | |||||||||
- | - | - | - | - | - | - | 0 | 87 | 35 |
Note borrowings | |||||||||
- | - | - | - | - | - | - | 19 | 0 | - |
Repayment of notes payable | |||||||||
- | - | - | - | - | - | - | 415 | 392 | 0 |
Proceeds from related party promissory note | |||||||||
355 | 1,000 | - | - | - | - | - | 0 | 540 | 0 |
Proceeds from exercise of warrants, net | |||||||||
- | - | - | - | 916 | 0 | - | 11 | 0 | - |
Borrowings under revolving note | |||||||||
- | - | - | - | 400 | 0 | - | - | - | - |
Repayments of term note | |||||||||
- | - | - | 100 | 300 | 0 | - | - | - | - |
Deferred offering costs from private placement | |||||||||
- | - | - | - | - | - | - | 6,869 | 2,480 | 0 |
Proceeds from issuance of common stock in private placement | |||||||||
1,850 | 978 | 2,944 | 5,141 | 0 | 6,234 | - | 0 | 0 | 0 |
Offering costs | |||||||||
- | - | - | - | - | - | 0 | -178 | -45 | 0 |
Net cash provided by financing activities | |||||||||
2,416 | 2,342 | 2,842 | 5,041 | 1,591 | 6,234 | 0 | 6,307 | 2,670 | 35 |
Net increase in cash | |||||||||
49 | -908 | -943 | 987 | -688 | 1,116 | -3,529 | 3,918 | 61 | -0 |
Interest | |||||||||
- | - | 2 | 34 | - | - | - | - | - | - |
Interest | |||||||||
- | 1 | - | - | 13 | 4 | 0 | 15 | 0 | 0 |
Income taxes | |||||||||
- | - | - | 0 | 4 | 2 | 2 | 2 | 0 | 0 |
Supplemental schedule of non-cash investing and financing activities: | |||||||||
Conversion of related party promissory note payable into shares of common stock | |||||||||
250 | - | - | - | - | - | - | - | - | - |
Reclassification of deferred offering costs to additional paid in capital | |||||||||
- | 6 | 23 | - | - | - | - | - | - | - |
Shares issued for private placement fee | |||||||||
- | - | - | - | - | 355 | - | - | - | - |
Warrants issued with common stock | |||||||||
- | - | - | - | - | 4,973 | 0 | - | - | - |
Patent acquired in exchange for royalties obligation | |||||||||
- | - | - | - | - | 101 | - | - | - | - |
Patent acquired in exchange for royalties obligation | |||||||||
- | - | - | - | - | - | 0 | - | - | - |
Forfeiture of restricted stock for prepaid consulting services | |||||||||
- | - | - | - | - | -70 | 0 | - | - | - |
Incremental fair value resulting from warrant modification | |||||||||
- | - | - | - | 225 | 0 | - | - | - | - |
Conversion of revolving note to term note | |||||||||
- | - | - | - | 400 | 0 | - | - | - | - |
Shares issued under Make-Whole Share provision | |||||||||
- | - | - | - | 430 | - | - | - | - | - |
Issuance of common stock upon conversion of convertible note | |||||||||
- | - | - | 621 | 0 | - | - | - | - | - |
Shares issued under Make-Whole Share provision | |||||||||
- | - | - | - | - | 0 | - | - | - | - |
Stock issued for prepaid consulting services | |||||||||
- | - | - | - | - | - | 70 | - | - | - |
Offering costs paid by stockholder | |||||||||
- | - | - | - | - | - | - | 0 | 25 | 0 |
Conversion of stockholder loan and interest into common stock | |||||||||
- | - | - | - | - | - | - | 546 | 2 | - |
Conversion of stockholder loan into common stock | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Conversion of stockholder loan into capital - no shares issued | |||||||||
- | - | - | - | - | - | - | 0 | 22 | 0 |
Conversion of 9,767 warrants into 1,954 common shares | |||||||||
- | - | - | - | - | - | - | 44 | 0 | - |
Conversion of 150,600 warrants into 30,121 common shares | |||||||||
- | - | - | - | - | - | - | 722 | - | - |
Note payable - insurance financing | |||||||||
- | - | - | - | - | - | - | 0 | 42 | 0 |
Note issued for accounts payable | |||||||||
- | - | - | - | - | - | - | 0 | 0 | 7 |
Acquisition of intellectual property through note payable | |||||||||
- | - | - | - | - | - | - | 0 | 700 | 0 |
Financing costs through issuance of restricted common stock | |||||||||
- | - | - | - | - | - | - | 20 | 60 | 0 |
Conversion of derivative liability to accrued expense | |||||||||
- | - | - | - | - | - | 150 | 0 | - | - |
Stock issued for prepaid consulting | |||||||||
- | - | - | - | - | - | - | 0 | - | - |